You searched for "Ophthalmology"
What’s new in glaucoma? Clinical trials drive practice changes, surgical advancements gather pace
Rod McNeil reviews the latest developments in the treatment of glaucoma in the UK. Primary open-angle glaucoma (POAG), which accounts for over two-thirds of all glaucoma cases, has an estimated UK prevalence in 2017 of approximately 2% of people over...
Ophthalmic DOPS and OSATS: The Handbook for Work-Based Assessments
The first thing to say is: “I wish I’d had this book when I was an ST1!” The number of work-based assessments (WBA) required during ophthalmic specialist training (OST) is a daunting prospect to trainee ophthalmologists, particularly ST1s with no...Postgraduate training for ophthalmic practitioners
The UK currently spends £25 billion per year on ocular disease, and there is expected to be a 40% increase in those affected by visual impairment by 2050 [1]. To manage this demand, 82% of ophthalmology units across the UK...Lockdown and eye health – a case of accommodative spasm
A 25-year-old male presented to the eye casualty with a one-day history of sudden onset worsening vision. More specifically, he noted his vision was more blurred than usual and this was more exaggerated for near-work than for distance-work. He was...RCOphth Annual Congress - Day 4
Live updates from the final day at the RCOphth 2022 Annual Congress.What's trending Aug/Sep 2018
A round-up of the eye related hot topics that have been trending on social media over the last few weeks. #QueenElizabeth #cataract It is well and truly summer! Queen Elizabeth was spotted in her sunnies during recent events, not just...Progress in retinal disease management: Highlights of the Retina Day, RCOphth 2025 Annual Congress
The Retina Day meeting at the Royal College of Ophthalmologists (RCOphth) 2025 Annual Congress in Liverpool was held on 22 May 2025. This report highlights 10 selected topics of interest to subspecialists and general ophthalmologists. Decarbonising anti-VEGF clinics (or making...Recurrent corneal erosions secondary to isotretinoin use
Isotretinoin (13–cis-retinoic acid) is the first line treatment for moderate to severe nodulocystic or papulopustular acne [1,2]. Although it is a safe medication, it has several adverse side-effects, including ophthalmic manifestations, as shown in Table 1 [3]. These side-effects need...Tough gig
‘The times they are a-changin’. The words of this Dylan classic resonate down the decades, and in the light of recent events, speak eloquently to life in 2022. It feels like a lifetime of change has passed since the Eye...Grading of ocular inflammation in uveitis: an overview
Anterior uveitis is the commonest form of uveitis, which can lead to severe morbidity if not treated appropriately [1]. Data from general ophthalmology practices suggest around 90% of uveitis encountered by comprehensive ophthalmologists is anterior uveitis [2]. Intermediate (vitreous), posterior...Useful digital resources for the modern ophthalmologist
In the age of the internet and a smartphone at everyone’s fingertips, here are some free resources I have found to be useful on the job, and hopefully will be of use to you too. Feedly (Android/iOS): Better known as...
